Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

In vivo analysis of the infection dynamics of influenza and human RSV in naive and immunized mice with the use of recombinant reporter viruses.

Outputs and Outcomes

Code

31506714

Duration

01 January 2014 → 31 December 2016

Funding

Research Foundation - Flanders (FWO)

Promotor

Xavier Saelens

Research disciplines

Natural sciences
- Molecular evolution
Medical and health sciences
- Infectious diseases
- Virology
- Pathophysiology

Keywords

in vivo influenza viruses

Project description

RSV and influenza viruses are important human pathogens. Our lab developed a novel RSV vaccine candidate and a broadly protective influenza vaccine. These vaccines elicit non neutralizing protection against these viruses. We will generate recombinant influenza and RSV viruses to study the dynamics of these viruses in the context of such so called infection permissive vaccines.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by